Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566447 · ClinicalTrials.gov registry record
"Solana™ Trichomonas Assay Field Study"
A clinical trial of Trichomonas Vaginalis, sponsored by Quidel Corporation.
- Completed
- Registry status
- 750
- Enrollment target
- 4
- Study locations
NCT02566447 is a study of Trichomonas Vaginalis that has completed, run by Quidel Corporation. The registered enrollment target is 750 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT02566447, a study of Trichomonas Vaginalis, has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
- 4
- Study locations
Study Summary
The Solana® Trichomonas Assay is an in vitro qualitative nucleic acid amplification test for the detection of Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Helicase-Dependent Amplification (HDA) technology and the Solana instrument.
Conditions Studied
Interventions
- DEVICE Solana Trichomonas Assay Testing
Study Locations (4)
Alabama
- University of Alabama at Birmingham - Birmingham
Maryland
- Johns Hopkins University School of Medicine - Baltimore
North Carolina
- University of North Carolina, Div. of Infectious Diseases - Chapel Hill
Washington
- University of Washington in Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2015-10-15 |
| Est. Completion | 2016-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02566447
The ClinicalTrials.gov registry entry for NCT02566447 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trichomonas Vaginalis appearing as the primary indexed condition, and to 1 intervention - of which Solana Trichomonas Assay Testing is the first listed.
NCT02566447 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Maryland, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02566447 about?
NCT02566447 is a clinical study titled ""Solana™ Trichomonas Assay Field Study"". The Solana® Trichomonas Assay is an in vitro qualitative nucleic acid amplification test for the detection of Trichomonas vaginalis to aid in the diagnosis of trichomoniasis using the Helicase-Dependent Amplification (HDA) technology and the Solana instrument.
What is the current status of trial NCT02566447?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2015-10-15. Estimated completion is 2016-08-15.
What conditions does trial NCT02566447 study?
This clinical trial studies the following conditions: Trichomonas Vaginalis.
What interventions are being tested in trial NCT02566447?
The interventions under investigation include: Solana Trichomonas Assay Testing (DEVICE).
Who is sponsoring clinical trial NCT02566447?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02566447 being conducted?
This trial has 4 study locations across Alabama, Maryland, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trichomonas Vaginalis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.